These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18209879)

  • 1. Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity.
    Espíndola-Antunes D; Kater CE
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1397-403. PubMed ID: 18209879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.
    Bujalska IJ; Kumar S; Hewison M; Stewart PM
    Endocrinology; 1999 Jul; 140(7):3188-96. PubMed ID: 10385414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
    Tomlinson JW; Moore JS; Clark PM; Holder G; Shakespeare L; Stewart PM
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2711-6. PubMed ID: 15181046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
    Stomby A; Andrew R; Walker BR; Olsson T
    Diabetologia; 2014 Jun; 57(6):1100-10. PubMed ID: 24710966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome--11beta-hydroxysteroid dehydrogenase type 1.
    Stewart PM
    Clin Med (Lond); 2005; 5(2):142-6. PubMed ID: 15847006
    [No Abstract]   [Full Text] [Related]  

  • 11. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity.
    Michailidou Z; Jensen MD; Dumesic DA; Chapman KE; Seckl JR; Walker BR; Morton NM
    Obesity (Silver Spring); 2007 May; 15(5):1155-63. PubMed ID: 17495191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
    Seckl JR; Morton NM; Chapman KE; Walker BR
    Recent Prog Horm Res; 2004; 59():359-93. PubMed ID: 14749510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
    Walker BR; Andrew R
    Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal women.
    Andersson T; Simonyte K; Andrew R; Strand M; Burén J; Walker BR; Mattsson C; Olsson T
    PLoS One; 2009 Dec; 4(12):e8475. PubMed ID: 20041117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen reduces 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats.
    Andersson T; Söderström I; Simonyté K; Olsson T
    Obesity (Silver Spring); 2010 Mar; 18(3):470-5. PubMed ID: 19763091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different expression and distribution of 11beta-hydroxysteroid dehydrogenase type 1 in obese and lean animal models of type 2 diabetes.
    Czegle I; Margittai E; Senesi S; Benedetti A; Bánhegyi G
    Acta Physiol Hung; 2008 Dec; 95(4):419-24. PubMed ID: 19009916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.
    Stulnig TM; Waldhäusl W
    Diabetologia; 2004 Jan; 47(1):1-11. PubMed ID: 14652720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.
    Morton NM
    Mol Cell Endocrinol; 2010 Mar; 316(2):154-64. PubMed ID: 19804814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis.
    Campbell JE; Fediuc S; Hawke TJ; Riddell MC
    Metabolism; 2009 May; 58(5):651-60. PubMed ID: 19375588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.